IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of IRIDEX (NASDAQ:IRIX) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

IRIDEX Trading Down 0.8 %

Shares of IRIDEX stock opened at $1.26 on Friday. IRIDEX has a 1 year low of $1.22 and a 1 year high of $3.65. The company’s fifty day simple moving average is $1.58 and its 200-day simple moving average is $1.69. The company has a market cap of $20.96 million, a price-to-earnings ratio of -1.88 and a beta of 0.94. The company has a current ratio of 1.54, a quick ratio of 0.85 and a debt-to-equity ratio of 0.55.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.